Allergan has joined the TriNetX global health research network for real-time access to patient populations, driven and refreshed by clinical data, to determine protocol feasibility, cohort analysis and site identification.   TriNetX’s cloud-based platform, TNX™, provides on-demand access to longitudinal clinical data and a set of highly intuitive analytics capabilities, enabling researchers to design successful protocols, improve site selection and planning, and create real-world evidence (RWE...